In addition, the drug has been shown to reduce fasting blood glucose by stimulating insulin secretion and lowering glucagon secretion when blood glucose is high [41, 50], which is crucial for preventing complications associated with hyperglycemia [51]. The gene discussed is INS; the disease is Hyperglycemia.